MARKER THERAPEUTICS, INC. (MRKR) Return on equity 2017–2025
MARKER THERAPEUTICS, INC. (MRKR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-72.4%FY2025 · since FY2017: -300.2% → -72.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -72.4% | -14.6 pp |
| FY2024 | -57.8% | +0.8 pp |
| FY2023 | -58.6% | +94.1 pp |
| FY2022 | -152.7% | -57.5 pp |
| FY2021 | -95.2% | +9.8 pp |
| FY2020 | -105.0% | -56.4 pp |
| FY2019 | -48.6% | +200.7 pp |
| FY2018 | -249.3% | +50.9 pp |
| FY2017 | -300.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice